Tomorrow Review

Is Tomorrow worth it?

Tomorrow's whole pitch comes down to this: people who want compounded GLP-1 injections or under-the-tongue drops on a true monthly plan. It runs $199/month — a premium versus the rest of the category, so its specific extras need to earn that difference. Its standout is a needle-free oral option, which very few providers offer.

Beyond the medication itself, Tomorrow charges no membership fee and takes HSA/FSA payment.

How much Tomorrow actually costs

Compounded semaglutide runs $199/month, compounded semaglutide runs $199/month, compounded tirzepatide runs $299/month, compounded tirzepatide runs $299/month, brand-name semaglutide runs $1699/month, and brand-name tirzepatide runs $1399/month.

For context, the typical ongoing price across the GLP-1 providers we track is around $170/month. Tomorrow's standing rate sits at the premium end of that range, well above the cheapest options in the category.

For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against Tomorrow before you commit.

Medications: what Tomorrow prescribes

Tomorrow prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.

Tomorrow's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Tomorrow is best for — and who should skip it

A good fit if you…

• are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.

Look elsewhere if you…

• want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
• need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

Tomorrow costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.